{"log_id": 2660994299720222694, "direction": 0, "words_result_num": 34, "words_result": [{"probability": {"variance": 0.033766, "average": 0.814632, "min": 0.371221}, "location": {"width": 539, "top": 383, "height": 41, "left": 406}, "words": "禁用于动除搭手手术CABG)用手术疗钓治"}, {"probability": {"variance": 0.014319, "average": 0.938531, "min": 0.462809}, "location": {"width": 568, "top": 429, "height": 41, "left": 406}, "words": "有应用非抗炎药后发生胃肠道出血或穿孔病史的忠者"}, {"probability": {"variance": 0.024116, "average": 0.879407, "min": 0.408297}, "location": {"width": 603, "top": 475, "height": 41, "left": 406}, "words": "有活动性消化读病/出血,减古让曾复发溃疡出血的患名"}, {"probability": {"variance": 0.0412, "average": 0.767305, "min": 0.379127}, "location": {"width": 182, "top": 523, "height": 29, "left": 406}, "words": "重心力衰竭想"}, {"probability": {"variance": 0.023776, "average": 0.859783, "min": 0.599266}, "location": {"width": 123, "top": 566, "height": 29, "left": 383}, "words": "【注意亚】"}, {"probability": {"variance": 0.010031, "average": 0.890544, "min": 0.779978}, "location": {"width": 118, "top": 614, "height": 29, "left": 372}, "words": "心血风险"}, {"probability": {"variance": 0.037745, "average": 0.846881, "min": 0.369175}, "location": {"width": 957, "top": 655, "height": 50, "left": 372}, "words": "针对多种环氧2(Cx-2选择性或非选择性 NSAID纠妆持线间间达3年的临床试验显示,本"}, {"probability": {"variance": 0.023896, "average": 0.915891, "min": 0.37535}, "location": {"width": 959, "top": 703, "height": 50, "left": 370}, "words": "昌可能引起产心血管血栓性不良件、心肌梗死和卒中的风险增,其风险可能致命的,所"}, {"probability": {"variance": 0.027302, "average": 0.869112, "min": 0.391107}, "location": {"width": 954, "top": 751, "height": 47, "left": 372}, "words": "有的 NSAIDS,包括COx-2择性或选择性药物,可能有相似的风。有心血管疾病或心血管"}, {"probability": {"variance": 0.007901, "average": 0.948451, "min": 0.674533}, "location": {"width": 347, "top": 797, "height": 38, "left": 372}, "words": "疾俩危险因亲的忠者,其风险更大"}, {"probability": {"variance": 0.043046, "average": 0.802247, "min": 0.453138}, "location": {"width": 116, "top": 842, "height": 34, "left": 370}, "words": "胃肠风险"}, {"probability": {"variance": 0.023857, "average": 0.926953, "min": 0.357361}, "location": {"width": 929, "top": 890, "height": 47, "left": 374}, "words": "在佳用所有NSAD治疗过程中的任时候,都可能山现胃道出血、溃疡和穿孔的不良反应"}, {"probability": {"variance": 0.039542, "average": 0.873461, "min": 0.355793}, "location": {"width": 952, "top": 936, "height": 50, "left": 370}, "words": "其凤险可能足致命的。这些不泛反应可能有或不伴有示症状,也不论患是否有胃道不良"}, {"probability": {"variance": 0.018304, "average": 0.918924, "min": 0.522477}, "location": {"width": 952, "top": 984, "height": 50, "left": 370}, "words": "反应史或严重的肠道事件病史,既往有溃疡性结肠炎,克隆氏病的恐者应谨慎使用非甾体抗炎"}, {"probability": {"variance": 0.019, "average": 0.908817, "min": 0.459266}, "location": {"width": 957, "top": 1030, "height": 52, "left": 367}, "words": "药,以免使病情恶化。当出者肢用该药发生肠选出血溃疡时,应停药。老年忠者使用非体"}, {"probability": {"variance": 0.022715, "average": 0.921335, "min": 0.461564}, "location": {"width": 824, "top": 1080, "height": 45, "left": 367}, "words": "抗炎到出现不良反应的频率增加,尤其是写肠道出血和穿孔,其风除可能足致命的"}, {"probability": {"variance": 0.009809, "average": 0.8244, "min": 0.725362}, "location": {"width": 45, "top": 1128, "height": 27, "left": 370}, "words": "雪告"}, {"probability": {"variance": 0.042465, "average": 0.842088, "min": 0.472602}, "location": {"width": 116, "top": 1176, "height": 29, "left": 370}, "words": "心血管影响"}, {"probability": {"variance": 0.067927, "average": 0.712002, "min": 0.35958}, "location": {"width": 182, "top": 1222, "height": 29, "left": 372}, "words": "心血栓性事件"}, {"probability": {"variance": 0.026426, "average": 0.903455, "min": 0.363199}, "location": {"width": 954, "top": 1267, "height": 47, "left": 367}, "words": "长使用本品可能引起重心血管止栓性不良件、心梗死中的风险增加,其风险可能是"}, {"probability": {"variance": 0.013558, "average": 0.932955, "min": 0.422596}, "location": {"width": 954, "top": 1313, "height": 52, "left": 365}, "words": "致命的所有的 NSALDSR包括COX-2选择性或非选择性药物,可能有相似的风险。有心血疾"}, {"probability": {"variance": 0.022905, "average": 0.911582, "min": 0.414214}, "location": {"width": 970, "top": 1359, "height": 52, "left": 342}, "words": "病心管病危验因素的思者,其风险更大。为了使接受本品治疗的忠者发生心血管不良"}, {"probability": {"variance": 0.03801, "average": 0.901721, "min": 0.367831}, "location": {"width": 909, "top": 1411, "height": 45, "left": 411}, "words": "在网最小化,应尽可能在经短疗内使用最低有效剂量。即使既往没有心血管症状.医生"}, {"probability": {"variance": 0.027066, "average": 0.921591, "min": 0.355681}, "location": {"width": 954, "top": 1459, "height": 45, "left": 365}, "words": "和啡者应对此类事件的发生保持警惕应告知者严重心血管安全性的症状和或体征以及如果"}, {"probability": {"variance": 0.024837, "average": 0.916813, "min": 0.530117}, "location": {"width": 185, "top": 1510, "height": 29, "left": 367}, "words": "发生应采取的步骤"}, {"probability": {"variance": 0.026473, "average": 0.898516, "min": 0.352638}, "location": {"width": 952, "top": 1553, "height": 47, "left": 365}, "words": "患者应该密惕诸如气短、元力、言语含糊等症状和体证,而且当有任何上述症状或体征发"}, {"probability": {"variance": 0.000355, "average": 0.98408, "min": 0.943535}, "location": {"width": 189, "top": 1601, "height": 34, "left": 363}, "words": "生后应该马上就诊"}, {"probability": {"variance": 0.097728, "average": 0.66844, "min": 0.355825}, "location": {"width": 68, "top": 1649, "height": 27, "left": 370}, "words": "高"}, {"probability": {"variance": 0.020895, "average": 0.910062, "min": 0.444562}, "location": {"width": 954, "top": 1692, "height": 47, "left": 363}, "words": "和所有NSAs一样,本品可导新发高血压使已有的高血压痕状加重,其中的江何一种都"}, {"probability": {"variance": 0.03516, "average": 0.871797, "min": 0.380297}, "location": {"width": 952, "top": 1740, "height": 45, "left": 365}, "words": "导致心血管事件的发生半地加用塞嗪类或袢利尿剂的患者腿用 NSAIID时,可能会响这"}, {"probability": {"variance": 0.027368, "average": 0.894022, "min": 0.38926}, "location": {"width": 952, "top": 1788, "height": 45, "left": 363}, "words": "些药牧的前效高血压病者应消用 NSAIDS,包括本品。在开始本品治疗和整个治疗过程中应"}, {"probability": {"variance": 0.048345, "average": 0.811278, "min": 0.44783}, "location": {"width": 141, "top": 1836, "height": 29, "left": 363}, "words": "密切监游压"}, {"probability": {"variance": 0.041943, "average": 0.845492, "min": 0.4229}, "location": {"width": 228, "top": 1887, "height": 29, "left": 370}, "words": "瓶血性心力和水"}, {"probability": {"variance": 0.032158, "average": 0.901127, "min": 0.351872}, "location": {"width": 950, "top": 1932, "height": 45, "left": 367}, "words": "本品已有临床研究中未发生充血性心力衰端和水肿事件。据文报进一些服NSAD包括塞来"}], "language": 3}